Cannabis Bioscience International Holdings (CBIH) EBITDA Margin (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly EBITDA Margin came in at 832.3% in Q1 2026, up 3324.0% year-on-year from 24.31% in Q1 2025, and down 362.4% quarter-over-quarter from 180.0% in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) EBITDA Margin (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed EBITDA Margin across 5 years of filings, most recently posting 832.3% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 832.3%, up 3324.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 322.6% (down 23069.0% YoY), and the FY2025 annual result was 139.05%, up 5631.0% from the prior year.
- EBITDA Margin came in at 832.3% for Q1 2026 at Cannabis Bioscience International Holdings, down from 180.0% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 39.06% in Q2 2024 to a low of 865.54% in Q1 2025.
- The 5-year median for EBITDA Margin is 275.89% (2023), against an average of 353.4%.
- Across the five-year window, EBITDA Margin jumped 55324 bps in 2024 and plunged 42619 bps in 2025, its largest moves.
- Cannabis Bioscience International Holdings' EBITDA Margin stood at 222.34% in 2022, then surged by 33 bps to 148.26% in 2023, then jumped by 46 bps to 80.31% in 2024, then tumbled by 124 bps to 180.0% in 2025, then sank by 362 bps to 832.3% in 2026.
- The last three EBITDA Margin figures came in at 832.3% (Q1 2026), 180.0% (Q4 2025), and 309.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -832.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -832.30% |
| Nov 30, 2025 | -180.00% |
| Aug 31, 2025 | -309.02% |
| May 31, 2025 | -385.91% |
| Feb 28, 2025 | -865.54% |
| Nov 30, 2024 | -80.31% |
| Aug 31, 2024 | -54.56% |
| May 31, 2024 | -39.06% |
| Feb 29, 2024 | -439.35% |
| Nov 30, 2023 | -148.26% |
| Aug 31, 2023 | -242.77% |
| May 31, 2023 | -592.30% |
| Feb 28, 2023 | -555.81% |
| Nov 30, 2022 | -222.34% |